# Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women

> **NCT02717494** · PHASE2 · COMPLETED · sponsor: **Westat** · enrollment: 347 (actual)

## Conditions studied

- PNC Vaccine
- HIV-infected Pregnant Women

## Interventions

- **BIOLOGICAL:** PPV-23
- **BIOLOGICAL:** PCV-10
- **OTHER:** NaCl

## Key facts

- **NCT ID:** NCT02717494
- **Lead sponsor:** Westat
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2018-11
- **Final completion:** 2019-05
- **Target enrollment:** 347 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717494, "Safety and Immunogenicity of Anti-Pneumococcal Vaccines in HIV-Infected Pregnant Women". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02717494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*